Revolution Medicines raises ~$823M in underwritten public offering of common stock and pre-funded warrants

Revolution Medicines, Inc.

Offering of 16,576,088 common shares and pre-funded warrants for 2,173,917 shares closed Dec 5, 2024.
Public price $46.00 per share / $45.9999 per pre-funded warrant; underwriters purchased at $43.93/$43.9299.
Net proceeds ~$823M after discounts and expenses; underwriters' option exercised in full.
45-day lock-up on share sales by directors, officers and the company, subject to exceptions.
Underwriting led by J.P. Morgan, TD Securities, Goldman Sachs & Guggenheim Securities.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.